Marker Therapeutics (MRKR) EBT Margin (2016 - 2025)
Marker Therapeutics (MRKR) reported EBT Margin of 780.69% for Q4 2025, up 55475.0% year-over-year from N/an in Q4 2024, and up 581.6% quarter-over-quarter from 162.11% in Q3 2025.
Marker Therapeutics (MRKR) EBT Margin (2016 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has 9 years of EBT Margin data on file, last reported at 780.69% in Q4 2025.
- EBT Margin for Q4 2025 came in at 780.69%, up 55475.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 65.2% (down 4087.0% YoY), and the FY2025 annual result was 343.39%, down 18133.0% from the prior year.
- EBT Margin improved to 780.69% in Q4 2025 per MRKR's latest filing, from 162.11% in the prior quarter.
- Over five years, EBT Margin peaked at 1674.09% in Q4 2022 and troughed at 1373.6% in Q1 2025.
- A 4-year average of 173.6% and a median of 180.67% in 2023 frame the typical range for EBT Margin.
- On a YoY basis, EBT Margin climbed as much as 147685 bps in 2023 and fell as far as 193309 bps in 2023.
- A 4-year view of EBT Margin shows it stood at 1674.09% in 2022, then slumped by 115 bps to 259.0% in 2023, then jumped by 187 bps to 225.94% in 2024, then soared by 246 bps to 780.69% in 2025.
- Business Quant data shows MRKR's EBT Margin at 780.69% in Q4 2025, 162.11% in Q3 2025, and 479.92% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 780.69% |
| Sep 30, 2025 | -162.11% |
| Jun 30, 2025 | -479.92% |
| Mar 31, 2025 | -1,373.60% |
| Dec 31, 2024 | 225.94% |
| Sep 30, 2024 | -119.84% |
| Jun 30, 2024 | -109.63% |
| Mar 31, 2024 | -192.34% |
| Dec 31, 2023 | -259.00% |
| Sep 30, 2023 | -1,157.57% |
| Jun 30, 2023 | 814.90% |
| Mar 31, 2023 | -168.99% |
| Dec 31, 2022 | 1,674.09% |
| Sep 30, 2022 | -572.92% |
| Jun 30, 2022 | -661.95% |
| Mar 31, 2022 | -1,015.39% |
| Jun 30, 2020 | -1,358.59% |
| Dec 31, 2019 | -2,588.58% |
| Jun 30, 2018 | -2,268.90% |
| Sep 30, 2017 | -2,179.30% |